Nicholas N. Vahanian

2009

In 2009, Nicholas N. Vahanian earned a total compensation of $1.7M as President and Chief Medical Officer at NewLink Genetics.

Compensation breakdown

Non-Equity Incentive Plan$179,966
Option Awards$1,203,689
Salary$256,316
Other$34,496
Total$1,674,467

Vahanian received $1.2M in option awards, accounting for 72% of the total pay in 2009.

Vahanian also received $180K in non-equity incentive plan, $256.3K in salary and $34.5K in other compensation.

Rankings

In 2009, Nicholas N. Vahanian's compensation ranked 2,869th out of 9,885 executives tracked by ExecPay. In other words, Vahanian earned more than 71.0% of executives.

ClassificationRankingPercentile
All
2,869
out of 9,885
71st
Division
Manufacturing
998
out of 3,690
73rd
Major group
Chemicals And Allied Products
195
out of 866
78th
Industry group
Drugs
114
out of 638
82nd
Industry
Pharmaceutical Preparations
91
out of 446
80th
Source: SEC filing on September 21, 2012.

Vahanian's colleagues

We found four more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2009.

2009

Charles Link

NewLink Genetics

Chairman

2009

Gordon Link

NewLink Genetics

Chief Financial Officer

2009

Kenneth Lynn

NewLink Genetics

Executive Vice President of Business Development

2009

W Ramsey

NewLink Genetics

Quality Assurance Officer

News

In-depth

You may also like